Zyprexa again
The anti-psychotic Zyprexa is making headlines, again. The amount of money Eli Lilly is paying to defend itself and its tactics in marketing the drug is rising (estimated to be now more than 0.2 billion US dollars since 2004 ). Zyprexa is also one of the most profitable Anti-psychotic medications …